Tendon rupture associated with simvastatin/ezetimibe therapy.

[1]  N. Maffulli,et al.  Biology of tendon injury: healing, modeling and remodeling. , 2006, Journal of musculoskeletal & neuronal interactions.

[2]  G. Riley.  Chronic tendon pathology: molecular basis and therapeutic implications , 2005, Expert Reviews in Molecular Medicine.

[3]  P. Libby,et al.  Inflammation, Immunity, and HMG-CoA Reductase Inhibitors: Statins as Antiinflammatory Agents? , 2004, Circulation.

[4]  T. Ritty,et al.  Tendon cells produce gelatinases in response to type I collagen attachment , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[5]  P. Thompson,et al.  Statin-associated myopathy. , 2003, JAMA.

[6]  R. Bank,et al.  Matrix metalloproteinase activities and their relationship with collagen remodelling in tendon pathology. , 2002, Matrix biology : journal of the International Society for Matrix Biology.

[7]  G. Hayem,et al.  Four cases of tendinopathy in patients on statin therapy. , 2001, Joint, bone, spine : revue du rhumatisme.

[8]  J. McEwan,et al.  Matrix metalloproteinases and cardiovascular disease. , 1995, Circulation research.

[9]  H. Birkedal‐Hansen,et al.  Matrix metalloproteinases: a review. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[10]  L. Matrisian,et al.  Metalloproteinases and their inhibitors in matrix remodeling. , 1990, Trends in genetics : TIG.

[11]  N. Turner,et al.  The FASEB Journal express article 10.1096/fj.04-2852fje. Published online February 23, 2005. ©2005 FASEB , 2022 .